Venture Capital
-
Venture capital deals
Kite Pharma Inc., a Los Angeles-based developer of targeted immunotherapies for cancer, has raised $20 million in new Series A funding. The company also converted $15 million of outstanding promissory notes into Series A preferred stock. Alta Partners led the round, and was joined by return backers like Pontifax Ltd., Commercial Street Capital, David Bonderman and Michael Milken. www.kitepharma.com
Pebble Inc., the smart-watch maker that was launched on Kickstarter, has raised $15 million in MORE
Dan Primack - May 17, 2013 11:13 AM ETPosted in: Venture Capital -
Venture capital deals
Apptio, a Bellevie, Wash.-based provider of on-demand technology business management solutions, has raised $45 million in Series E funding. Janus Capital, The Hillman Co. and an undisclosed "institutional investor" co-led the round, and were joined by return backers Andreessen Horowitz, Greylock Partners, Madrona Venture Group, Shasta Ventures and T. Rowe Price. The company has now raised a total of $136 million. www.apptio.com
AirWatch, an Atlanta-based provider of enterprise mobility management and security solutions, has raised MORE
Dan Primack - May 16, 2013 11:33 AM ETPosted in: Venture Capital -
Tableau Software raises IPO stakes
Tableau's venture capital backers getting ready for a monster return.
FORTUNE -- Tableau Software today increased the price range of its pending IPO to between $28 and $30 per share, meaning that it could raise upwards of $216 million when it prices tomorrow night. It had originally planned to price at between $23 and $26 per share.
And no one is happier about the bump than venture capital firm New Enterprise Associates, MORE
Dan Primack - May 15, 2013 1:47 PM ET -
Judge to CMEA Capital: No arbitration for you
Sexual harassment case against VC firm can proceed.
FORTUNE -- Venture capital firm CMEA Capital has lost its motion to compel arbitration in a sexual harassment suit brought against it by three former female employees. The complaint, filed in March, also alleges racial harassment and retaliation.
The San Francisco Superior Court judge also agreed to seal compensation history of the three plaintiffs: Dawn-Shemain Weeks, Margaret Hines and Shannon Schlagenhauf. The defense is expected to MORE
Dan Primack - May 15, 2013 11:43 AM ET -
Venture capital deals
Tokai Pharmaceuticals Inc., a Cambridge, Mass.-based developer of prostate cancer drugs, has raised $35.5 million in Series E funding. Return backers included Apple Tree Partners and Novartis Venture Funds. http://www.tokaipharmaceuticals.com
Privalia Venta Directa, a Spanish online private sales site, has raised €25 million in new VC funding. Sofina (Belgium) was joined by return backers Highland Capital Partners, General Atlantic, Insight Venture Partners, La Caixa Capital Risc, Index Ventures and Nauta Capital. The company previously raised MORE
Dan Primack - May 15, 2013 11:06 AM ETPosted in: Venture Capital -
Venture capital deals
Lanx Inc., a Broomfield, Colo.–based developer of devices for spine fusion surgery, has raised $15 million in Series C equity and debt funding. Credit Suisse Asset Management led the round, and was joined by Hercules Technology Growth Capital and return backers Chicago Growth Partners, Goldman Sachs Private Equity Opportunities Fund, Noro-Moseley Partners and Oakwood Medical Investors.www.lanx.com
Zoove Corp., a Palo Alto, Calif.-based provider of mobile direct response solutions for brands and content providers, MORE
Dan Primack - May 14, 2013 10:47 AM ETPosted in: Venture Capital -
Exclusive: Bloom Energy raises $130 million
Bloom Energy passes $1.1 billion in VC funding.
FORTUNE -- Fuel cell maker Bloom Energy has raised $130 million in new venture capital funding, Fortune has learned from multiple sources.
An unidentified new investor provided the first $100 million, while Credit Suisse (CS) provided the remaining $30 million. Existing investors did not participate in the round, which was structured as an extension to the company's Series G round that originally closed on MORE
Dan Primack - May 10, 2013 2:54 PM ETPosted in: Bloom Energy, Venture Capital -
Fool's gold in VC-land
Handing out pyrite for the vaunted Midas List.
FORTUNE -- Let's get this out of the way up-front: I write for Fortune, which is a competitor to Forbes. And as writers for either publication can tell you, readers mix the two up as if we were lesser Baldwin brothers at a Long Island barbecue. But my distaste for the Forbes Midas List -- its annual ranking of venture capitalists, which returned yesterday -- long predates MORE
Dan Primack - May 9, 2013 10:14 AM ETPosted in: Midas List, Venture Capital -
Donald Trump gets into crowdfunding
The Donald is willing to fund anything (literally).
FORTUNE -- Donald Trump is putting his stamp of approval, but not his name, on a new crowdfunding platform that is scheduled to launch tomorrow. He's also an investor in the site, and each week will personally contribute to one or more projects that strike his fancy.
It's called FundAnything, and was the brainchild of The Learning Annex founder Bill Zanker.
"People in tech and MORE
Dan Primack - May 7, 2013 3:57 PM ET -
CrunchFund's future
With nearly 100 portfolio companies and just two remaining partners, what is the future of Michael Arrington's venture capital effort?
FORTUNE -- It has been 20 months since TechCrunch founder Michael Arrington launched CrunchFund, a venture capital firm that had the blessing of AOL, the company that had purchased TechCrunch one year earlier. Until AOL changed its mind, and Arrington was fired. Until it changed its mind again, and he rejoined MORE
Dan Primack - May 7, 2013 3:23 PM ET
